Ivabradine Tablet
FDA Label NDC 70771-1863

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Ivabradine (NDC 70771-1863). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

Ivabradine Tablets, 5 mg

NDC 70771-1863-6

60 tablets

Rx only

5 mg (Af277139 633d 426c Bfdc D2115c4d1a12 01)

5 mg (Af277139 633d 426c Bfdc D2115c4d1a12 01)

Ivabradine Tablets, 5 mg

NDC 70771-1864-6

60 tablets

Rx only

7.5 mg (Af277139 633d 426c Bfdc D2115c4d1a12 02)

7.5 mg (Af277139 633d 426c Bfdc D2115c4d1a12 02)

* Please review the disclaimer below.